These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33061257)

  • 21. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.
    Kunert KS; Tisdale AS; Gipson IK
    Arch Ophthalmol; 2002 Mar; 120(3):330-7. PubMed ID: 11879137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials.
    Leonardi A; Doan S; Aragona P; Amrane M; Ismail D; Montero J; Németh J; Bremond-Gignac D
    Eye (Lond); 2023 Aug; 37(11):2320-2326. PubMed ID: 36564576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Topical Cyclosporine A Formulations-A Disease-Modifying Agent for Keratoconjunctivitis Sicca.
    Jerkins GW; Pattar GR; Kannarr SR
    Clin Ophthalmol; 2020; 14():481-489. PubMed ID: 32109984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
    Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
    Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
    Kim CE; Kleinman HK; Sosne G; Ousler GW; Kim K; Kang S; Yang J
    Sci Rep; 2018 Jul; 8(1):10500. PubMed ID: 30002412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye.
    Daull P; Nagano T; Gros E; Feraille L; Barabino S; Garrigue JS
    Curr Eye Res; 2021 Aug; 46(8):1096-1104. PubMed ID: 33588656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis.
    Thomas PB; Samant DM; Zhu Z; Selvam S; Stevenson D; Wang Y; Song SW; Mircheff AK; Schechter JE; Yiu SC; Trousdale MD
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):285-92. PubMed ID: 19456259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease.
    Hoy SM
    Drugs; 2017 Nov; 77(17):1909-1916. PubMed ID: 29110189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease.
    Coursey TG; Wassel RA; Quiambao AB; Farjo RA
    Transl Vis Sci Technol; 2018 Sep; 7(5):24. PubMed ID: 30323997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C; Celik I; Alkan F; Erol M; Sur E
    Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
    Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
    Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E; Yaylali V; Cetin EN; Yildirim C
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.
    Daull P; Barabino S; Feraille L; Kessal K; Docquier M; Parsadaniantz SM; Baudouin C; Garrigue JS
    Curr Eye Res; 2019 May; 44(5):476-485. PubMed ID: 30664361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
    Bang SP; Yeon CY; Adhikari N; Neupane S; Kim H; Lee DC; Son MJ; Lee HG; Kim JY; Jun JH
    PLoS One; 2019; 14(11):e0224805. PubMed ID: 31738791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P; Tesavibul N; Mahawong W
    Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease.
    Goldberg DF; Malhotra RP; Schechter BA; Justice A; Weiss SL; Sheppard JD
    Ophthalmology; 2019 Sep; 126(9):1230-1237. PubMed ID: 30965064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM; McGwin G; Liu B; Owsley C; Rosenstiel C
    Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.